09.05.2011
Dualsystems Biotech announces drug profiling agreement with PTC Therapeutics
Dualsystems Biotech today announced a drug profiling agreement with US-based PTC Therapeutics, Inc. Under the agreement, Dualsystems Biotech will use its drug profiling platform to identify molecular targets for an undisclosed small molecule candidate of PTC Therapeutics’ development pipeline.
- Related Files
- Download press release 232 K
Our satisfied customers say...
"The scientists at Dualsystems were helpful collaborators, very responsive to our requests, and screened additional libraries as needed to provide us with compelling data. The final results included several confirmed interacting proteins for our targets of interest and we were very satisfied with the yeast 2-hybrid service"